Evolutionary Genomics, Inc. Trading Securities, Realized Gain (Loss)
Evolutionary Genomics, Inc. reported Trading Securities, Realized Gain (Loss) of -$9.37 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-05.
Discontinued › Income Statement › Other Income
us-gaap:TradingSecuritiesRealizedGainLoss · last filed 2018-03-05
- Evolutionary Genomics, Inc. trading securities, realized gain (loss) for fiscal 2016 was -$9.37K.
- Evolutionary Genomics, Inc. trading securities, realized gain (loss) for fiscal 2015 was -$19.29K.
| Period end | Trading Securities, Realized Gain (Loss) 12 month |
|---|---|
| 2016-12-31 | -$9.37K 10-K · filed 2018-03-05 |
| 2015-12-31 | -$19.29K 10-K · filed 2017-02-10 |